# Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"

> **NCT06901908** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 45 (estimated)

## Conditions studied

- Suspicious for Papillary Thyroid Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06901908
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-11-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06901908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06901908, "Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06901908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*